Protocol for the proposed multi-national trial has been submitted for EU regulatory approval Company will...

NEW YORK, June 23, 2020 /PRNewswire/ — BrainStorm Cell Therapeutics Inc. (NasdaqCM: BCLI),  a leading developer of adult...

Allows for enrollment of up to 40 subjects in up to 20 centers SAN DIEGO, June...

Acquired assets expected to deliver attractive payback and achieve a production rate of 1,000 barrels of oil...

NEW YORK, June 15, 2020 (GLOBE NEWSWIRE) — BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading...

TULSA, OK, June 10, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — RJD Green (OTCPK: RJDG)...

The Dow Jones Industrial Average rallied on Friday after the latest U.S. jobs report raised...

Market news, S&P 500 and Nasdaq 100 futures were well off their lows, trading down...

Dow futures rise more than 200 points as optimism grows over the reopening of the...

The fully enrolled placebo-controlled Phase 3 trial is evaluating NurOwn® investigational treatment in ALS patients...